KC-5769

HCT15-ABCB1-KO Cell Line

×
59100
Home » HCT15-ABCB1-KO Cell Line

Background of HCT15-ABCB1-KO Cell Line

ABCB1 encodes ATP binding cassette subfamily B member 1 and is also known as CLCS. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13.

Specifications

Catalog NumberKC-5769
Cell Line NameHCT15-ABCB1-KO Cell Line
Clone Number1A4
Host Cell LineHCT15
DescriptionHCT15-ABCB1-KO is a stable cell line carrying targeted knockout modifications
QuantityOne vial of frozen cells (≥2×10⁶ cells/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% RPMI1640+20% FBS+10% DMSO
Propagation MediumRPMI1640+10%FBS
Selection MarkerNA
MorphologyEpithelial
SubcultureSplit at a ratio of 1:4–1:6 every 2–3 days
Incubation37 °C with 5% CO₂
StorageLiquid nitrogen immediately upon receiving
Doubling TimeEstimated 19–36 hours
Mycoplasma StatusNegative
In Vivo ValidationYES

Cell Line Generation

HCT15-ABCB1-KO cell line was generated using CRISPR/Cas9-mediated disruption of ABCB1.

Characterization

Figure 1: Characterization of HCT15-ABCB1-KO cell line stable clone using PCR sequencing.

Figure 2: Characterization of HCT15-ABCB1-KO cell line stable clone using RT-PCR sequencing.

Figure 3: Characterization of HCT15-ABCB1-KO cell line stable clone using FACS.

Figure 4: Characterization of HCT15-ABCB1-KO cell line stable clone using Western blot.

Cell Resuscitation

  1. Pre-warm complete culture medium (basal medium and 10% FBS) in a 37°C water bath.
  2. Rapidly thaw the cryovial in a 37°C water bath for 1-2 minutes with gentle agitation.
  3. Transfer the vial to a biosafety cabinet, and disinfect the exterior with 70% ethanol.
  4. Aseptically transfer the cell suspension dropwise into a sterile centrifuge tube containing 9.0 mL of pre-warmed complete medium.
  5. Centrifuge at approximately 125 × g for 5–7 minutes at room temperature, carefully aspirate the supernatant without disturbing the cell pellet.
  6. Gently resuspend the pellet in an appropriate volume of complete medium and transfer the suspension into a T25 flask.
  7. Incubate the flask in a 37°C in a humidified 5% CO₂ incubator.
  8. Assess cell viability and morphology after 24 hours. If cells appear healthy, replace the medium with fresh medium supplemented with the appropriate selective antibiotic.
  9. Subculture the cells at a ratio of 1:4–1:6 every 2–3 days upon reaching 80%–90% confluency.

Cell Freezing

  1. Prepare the freezing medium (70% basal medium, 20% FBS and 10% DMSO) freshly before use.
  2. Pre-chill the freezing medium on ice and label the cryovials accordingly.
  3. Transfer the cell suspension to a sterile conical tube and perform a cell count to determine total viability and density.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature; carefully aspirate the supernatant.
  5. Gently resuspend the pellet in chilled freezing medium, ensuring a minimum cell density of 3×10⁶ cells/mL.
  6. Aliquot 1 mL of the cell suspension into each pre-labeled cryovial.
  7. Place the cryovials into a CoolCell® container and store at -80°C overnight for controlled-rate cooling.
  8. Transfer the cryovials to the liquid nitrogen for long-term storage the following day.

References

  1. Dimulescu MD, Lungulescu CV, Riza AL et al. Association of germline ABCB1 and ERCC1 polymorphisms with CDK4/6 inhibitor-induced neutropenia in patients with breast cancer: a systematic review and meta-analysis. Frontiers in pharmacology. 2026;17:1872557. PMID: 42712445. doi: 10.3389/fphar.2026.1872557.
  2. De Luca F, Mannino D, Capra AP et al. ABCB1 Polymorphisms Influence on Temozolomide Resistance and Overall Survival in Glioblastoma Patients: A Systematic Review of Clinical Evidence. Journal of cellular and molecular medicine. 2026 Apr;30(7):e71130. PMID: 41957561. doi: 10.1111/jcmm.71130.
  3. Aldiban W, Hamam NG, Almosilhy NA et al. The role of ABCB1 and CES1 genotypes on the efficacy and safety of dabigatran: a systematic review and meta-analysis. Human genomics. 2025 Oct 22;19(1):121. PMID: 41126293. doi: 10.1186/s40246-025-00836-4.

Use License Agreement

Research Use Only.
Not for use in diagnostic procedures or therapeutic applications.
Redistribution of the cell line or its derivatives is prohibited without prior written permission from Kyinno Biotechnology.